• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情应对措施的比较分析:以土耳其为例。

A comparative analysis of the COVID-19 pandemic response: The case of Turkey.

作者信息

Simsek Engin Ersin, Guner Abdullah Emre, Kul Seval, Karakurt Zuhal, Tekesin Kemal, Birinci Suayip

机构信息

Department of Family Medicine, University of Health Sciences, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.

Department of Public Health Services, Provincial Directorate of Health, Istanbul, Turkey.

出版信息

North Clin Istanb. 2020 Oct 5;7(5):443-451. doi: 10.14744/nci.2020.87846. eCollection 2020.

DOI:10.14744/nci.2020.87846
PMID:33163879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7603852/
Abstract

OBJECTIVE

COVID-19 has spread worldwide and leads to an increased risk of mortality. We aimed to analyze what actions have been effective in fighting COVID-19 in Turkey with a comparison to pandemic-affected countries.

METHODS

This was a retrospective observational cross-sectional study. The Republic of Turkey Ministry of Health official web page includes data reported daily from 11 March to 26 April. Global COVID-19 data were recorded daily from https://www.worldometers.info/coronavirus/country/. Data were analyzed for 31 days according to Intensive Care Unit (ICU) admission, intubation and mortality rates. Segmented regression analysis was used. The results from COVID-19-affected countries were compared with the results from Turkey for the first 65 days.

RESULTS

In total, 889.742 tests were performed (positive=110.130 [12.37%]). The mortality rate was 2.55% (n=2805) on 27 April 2020. The annual percent change (APC) values of the cases showed 5 segments ([23.1], [14.7] [11.4], [3.7], [0.7]; each p=0.001). ICU admission showed 4 segments (APC: [3.1, p=0.001], [-2.2, p=0.10], [-7.6, p=0.001], [-4.5, p=0.001]). The decline of APC for intubation rates showed 5 segments (APC: [1.1, p=0.10], [-1.1,p=0.001], [-2.0, p=0.001], [-0.4, p=0.40], [-2.7, p=0.001]). The mortality rates showed 4 segments (APC: [-6.3, p=0.001], [8.4, p=0.001], [0.2, p=0.30], [1.4, p=0.001]). Deaths were reported per 1 million individuals for the first 65 days: Spain 11.6%, Italy 11.4%, UK 11.3%, France 11.1%, USA 10.3%, Germany 8.4%, Iran 8.2%, Turkey 7.5%, South Korea 4.1% and China 2.4%.

CONCLUSION

Public health policies and protocols to combat COVID-19 helped control the spread and decrease positive cases and mortality rates in Turkey. Turkey managed COVID-19 better than Spain, Italy, UK, France, USA and Turkey managed COVID-19 similarly to Germany and Iran. China and South Korea were best at managing COVID-19.

摘要

目的

新冠病毒病(COVID-19)已在全球传播并导致死亡风险增加。我们旨在分析在土耳其抗击COVID-19方面哪些行动是有效的,并与受疫情影响的国家进行比较。

方法

这是一项回顾性观察性横断面研究。土耳其共和国卫生部官方网页包含了3月11日至4月26日每日报告的数据。全球COVID-19数据每日从https://www.worldometers.info/coronavirus/country/记录。根据重症监护病房(ICU)收治率、插管率和死亡率对数据进行了31天的分析。采用了分段回归分析。将受COVID-19影响国家的结果与土耳其前65天的结果进行了比较。

结果

共进行了889,742次检测(阳性=110,130[12.37%])。2020年4月27日死亡率为2.55%(n=2805)。病例的年度百分比变化(APC)值显示有5个阶段([23.1],[14.7],[11.4],[3.7],[0.7];各p=0.001)。ICU收治显示有4个阶段(APC:[3.1,p=0.001],[-2.2,p=0.10],[-7.6,p=0.001],[-4.5,p=0.001])。插管率的APC下降显示有5个阶段(APC:[1.1,p=0.10],[-1.1,p=0.001],[-2.0,p=0.001],[-0.4,p=0.40],[-2.7,p=0.001])。死亡率显示有4个阶段(APC:[-6.3,p=0.001],[8.4,p=0.001],[0.2,p=0.30],[1.4,p=0.001])。前65天每100万人口中的死亡报告率为:西班牙11.6%,意大利11.4%,英国11.3%,法国11.1%,美国10.3%,德国8.4%,伊朗8.2%,土耳其7.5%,韩国4.1%,中国2.4%。

结论

抗击COVID-19的公共卫生政策和方案有助于控制土耳其的传播并降低阳性病例数和死亡率。土耳其在管理COVID-19方面比西班牙、意大利、英国、法国和美国做得更好,在管理COVID-19方面与德国和伊朗类似。中国和韩国在管理COVID-19方面表现最佳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467b/7603852/585b3eeb8bc8/NCI-7-443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467b/7603852/23cbe4f4e1bf/NCI-7-443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467b/7603852/585b3eeb8bc8/NCI-7-443-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467b/7603852/23cbe4f4e1bf/NCI-7-443-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/467b/7603852/585b3eeb8bc8/NCI-7-443-g002.jpg

相似文献

1
A comparative analysis of the COVID-19 pandemic response: The case of Turkey.新冠疫情应对措施的比较分析:以土耳其为例。
North Clin Istanb. 2020 Oct 5;7(5):443-451. doi: 10.14744/nci.2020.87846. eCollection 2020.
2
Global Interest in Telehealth During COVID-19 Pandemic: An Analysis of Google Trends™.新冠疫情期间全球对远程医疗的关注:谷歌趋势™分析
Cureus. 2020 Sep 16;12(9):e10487. doi: 10.7759/cureus.10487.
3
Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters.评估多个全球疫情中心 COVID-19 病例的大量漏报和漏检。
Pulmonology. 2021 Mar-Apr;27(2):110-115. doi: 10.1016/j.pulmoe.2020.05.015. Epub 2020 Jun 6.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
ICU admission rates in Istanbul following the addition of favipiravir to the national COVID-19 treatment protocol.在国家新冠病毒病治疗方案中加入法匹拉韦后伊斯坦布尔的重症监护病房收治率。
North Clin Istanb. 2021 Mar 22;8(2):119-123. doi: 10.14744/nci.2021.60420. eCollection 2021.
6
A close look at 2019 novel coronavirus (COVID 19) infections in Turkey using time series analysis & efficiency analysis.运用时间序列分析和效率分析对土耳其2019新型冠状病毒(COVID-19)感染情况进行深入研究。
Chaos Solitons Fractals. 2021 Feb;143:110583. doi: 10.1016/j.chaos.2020.110583. Epub 2020 Dec 23.
7
Positivity rate: an indicator for the spread of COVID-19.阳性率:COVID-19 传播的一个指标。
Curr Med Res Opin. 2021 Dec;37(12):2067-2076. doi: 10.1080/03007995.2021.1980868. Epub 2021 Oct 7.
8
Can judgments according to case fatality rate be correct all the time during epidemics? Estimated cases based on CFR in different scenarios and some lessons from early case fatality rate of coronavirus disease 2019 in Iran.在疫情期间,根据病死率做出的判断能一直正确吗?基于病死率在不同情景下估算病例数以及来自伊朗2019冠状病毒病早期病死率的一些经验教训。
Med J Islam Repub Iran. 2020 Mar 29;34:26. doi: 10.34171/mjiri.34.26. eCollection 2020.
9
Comparing South Korea and Italy's healthcare systems and initiatives to combat COVID-19.比较韩国和意大利抗击新冠疫情的医疗体系及举措。
Rev Panam Salud Publica. 2020 Apr 15;44:e53. doi: 10.26633/RPSP.2020.53. eCollection 2020.
10
Analysis and Forecasting Incidence, Intensive Care Unit Admissions, and Projected Mortality Attributable to COVID-19 in Portugal, the UK, Germany, Italy, and France: Predictions for 4 Weeks Ahead.葡萄牙、英国、德国、意大利和法国新冠肺炎发病率、重症监护病房收治情况及预计死亡率的分析与预测:未来4周预测
Bioengineering (Basel). 2021 Jun 11;8(6):84. doi: 10.3390/bioengineering8060084.

引用本文的文献

1
Impact of COVID-19 Pandemic on Utilization of Healthcare Services and Spending Patterns in Dubai, United Arab Emirates: A Cross-Sectional Study.2019年冠状病毒病疫情对阿拉伯联合酋长国迪拜医疗服务利用和支出模式的影响:一项横断面研究
Healthcare (Basel). 2024 Feb 14;12(4):473. doi: 10.3390/healthcare12040473.

本文引用的文献

1
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology.新型冠状病毒肺炎中的机械通气:解读当前流行病学情况
Am J Respir Crit Care Med. 2020 Jul 1;202(1):1-4. doi: 10.1164/rccm.202004-1385ED.
2
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.羟氯喹和阿奇霉素联合治疗 COVID-19 患者:法国马赛 1061 例回顾性分析。
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
3
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
美国传染病学会关于2019冠状病毒病患者治疗与管理的指南
Clin Infect Dis. 2020 Apr 27. doi: 10.1093/cid/ciaa478.
4
COVID-19 outbreak control, example of ministry of health of Turkey.新冠疫情防控:土耳其卫生部的范例。
Turk J Med Sci. 2020 Apr 21;50(SI-1):489-494. doi: 10.3906/sag-2004-187.
5
Crushing the curve, the role of national and international institutions and policy makers in COVID-19 pandemic.压平曲线:国家和国际机构及政策制定者在新冠疫情大流行中的作用
Turk J Med Sci. 2020 Apr 21;50(SI-1):495-508. doi: 10.3906/sag-2004-167.
6
Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis.羟氯喹治疗 COVID-19 患者的病毒学和临床治愈:系统评价和荟萃分析。
J Med Virol. 2020 Jul;92(7):776-785. doi: 10.1002/jmv.25898. Epub 2020 May 3.
7
School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review.新冠疫情期间包括 COVID-19 在内的冠状病毒爆发期间的学校关闭和管理措施:快速系统评价。
Lancet Child Adolesc Health. 2020 May;4(5):397-404. doi: 10.1016/S2352-4642(20)30095-X. Epub 2020 Apr 6.
8
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19.344例新冠肺炎重症监护患者的临床病程及预后
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1430-1434. doi: 10.1164/rccm.202003-0736LE.
9
Diagnosis and Management of COVID-19 Disease.新型冠状病毒肺炎的诊断与管理
Am J Respir Crit Care Med. 2020 May 15;201(10):P19-P20. doi: 10.1164/rccm.2020C1.
10
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.羟氯喹和阿奇霉素治疗 COVID-19:一项开放标签非随机临床试验的结果。
Int J Antimicrob Agents. 2020 Jul;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949. Epub 2020 Mar 20.